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Abstract: 
Background:  In recent years, an abstinence-focused, ‘recovery’ agenda has emerged in 
UK drug policy, largely in response to the perception that many opioid users had been 
‘parked indefinitely’ on Opioid Substitution Therapy (OST). The introduction of ten pilot 
‘Drug Recovery Wings’ (DRWs) in 2011 represents the application of this recovery 
agenda to prisons. This paper describes the DRWs’ operational models, the place of 
opiate dependent prisoners within them, and the challenges of delivering ‘recovery’ in 
prison. 
Methods: In 2013, the implementation and operational models of all ten pilot DRWs 
were rapidly assessed. Up to three days were spent in each DRW, undertaking semi-
structured interviews with a sample of 94 DRW staff and 102 DRW residents. Interviews 
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were fully transcribed, and coded using grounded theory. Findings from the nine adult 
prisons are presented here. 
Results: Four types of DRW were identified, distinguished by their size and 
selection criteria. Strikingly, no mid- or large-sized units regularly supported OST 
recipients through detoxification. Type A were large units whose residents were mostly 
on OST with long criminal records and few social or personal resources. Detoxification 
was rare, and medication reduction slow. Type B’s mid-sized DRW was developed as a 
psychosocial support service for OST clients seeking detoxification. However, staff 
struggled to find such prisoners, and detoxification again proved rare. Type C DRWs 
focused on abstinence from all drugs, including OST. Though OST clients were not 
intentionally excluded, very few applied to these wings. Only Type D DRWs, offering 
intensive treatment on very small wings, regularly recruited OST recipients into 
abstinence-focused interventions. 
Conclusion: Prison units wishing to support OST recipients in making greater progress 
towards abstinence may need to be small, intensive and take a stepped approach based on 
preparatory motivational work and extensive preparation for release. However, concerns 
about post-release deaths will remain. 
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Introduction: A Shifting Landscape: UK Drug Policy, Recovery, and Prisons. 
The British prison system receives over 130,000 admissions per year (Patel 2010:18), 
with 3,935 women and 82,042 men imprisoned as of November 2015 (Ministry of Justice 
2015). Many of these prisoners have problematic relationships with alcohol or drugs. The 
Report of the Prison Drug Strategy Review Group (Patel 2010) noted that 69% of new 
prisoners identify that they have used drugs in the previous year, with 40% of these 
reporting injected drug use within the preceding 28 days (2010:18-19). This scales up to 
present a substantial organisational challenge to both prison and health services, with 
64,379 Opioid Substitution Therapy (OST) treatment episodes in English prisons in 
2012-13 (Hansard 3
rd
 December 2012: column 667W).  
Following their election in 2010, criminal justice drug treatment offered an opportunity 
for the UK’s Coalition Government to establish a new approach to a longstanding 
political concern, breaking the ‘drugs-crime cycle’ (e.g. Home Affairs Committee 2012). 
The Coalition’s first Drug Strategy consequently announced an initiative bringing ‘wing-
based, abstinence focused, drug recovery services’ to English and Welsh prisons (HM 
Govt 2010:12). A Ministry of Justice Green Paper contemporaneously highlighted a 
renewed ‘focus on recovery outcomes, challenging offenders to come off drugs,’ 
identifying ‘pilot Drug Recovery Wings’ (DRWs) as a key vehicle for achieving these 
ends (MoJ 2010:29). This emphasis on abstinence and recovery, and the absence of any 
mention of heroin users, marked a clear ideological shift away from the policies of the 
preceding ten years. 
In early 2011, five prisons formed the first tranche of DRW pilot sites. These wings were 
in one Category A and four Category B men’s prisons (Category A represents the highest, 
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and Category D the lowest men’s security categorisation). They were principally 
expected to… 
…offer a route out of dependency for those who are motivated to change… 
increase the number of short sentenced offenders participating in recovery-focused 
interventions and… improve continuity of care… between prisons and the 
community (Powis, Walton and Randhawa 2014:1). 
In April 2012, five additional prisons began hosting pilot DRWs. These included two 
women’s prisons, a Young Offender’s Institution (YOI), and two Category B men’s 
prisons (PIRU 2012:2). Host prisons received no additional year-on-year resourcing, 
though some received £30,000 to fund local evaluations and / or set-up costs. In line with 
the 2010 Drug Strategy’s call for services to be “locally owned and locally led” (HM 
Govt 2010:19), all DRWs were expected to develop distinctive operational models 
tailored to local needs (MoJ 2010:82).  
Though Government documents shied away from explicitly identifying abstinence from 
OST as DRWs’ core goal, this was a clear part of their conceptual evolution. DRWs fit 
within a broader recovery movement, which emerged as a reaction to the long-term 
dominance of treatment services by heroin users receiving OST. The term ‘heroin users’ 
is significant here, as the rise of OST can be explicitly traced back to a drive by New 
Labour to address the social problems – and particularly the high levels of offending – 
associated with heroin use (e.g. Godfrey et al 2003; Boreham et al., 2007; HM Govt 
2002; Holloway and Bennett 2004; HM Govt 2008). Under a process described 
somewhat awkwardly by Seddon, Williams and Ralphs as the ‘riskification’ of UK drug 
services (2012:39), New Labour ensured that drug workers were placed at every stage of 
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the criminal justice system tasked with providing heroin using offenders with rapid 
access to OST, usually in the form of methadone maintenance (Duke 2013:47; HM Govt 
2002). As the strapline for the Drug Interventions Programme, a headline New Labour 
initiative, surmised: ‘out of crime, into treatment’ (e.g. Home Office 2008). On one level, 
this approach was highly successful. By 2006, New Labour had met its aspiration to 
double the numbers in treatment (HM Govt  2002:11; HM Govt  2008:4). Many of these 
were referred directly into OST by criminal justice agencies (e.g. Jones et al 2007; 
Skodbo et al 2007).  
However, a shift in perspective then led to OST being reframed as a problematic drug 
dependence in and of itself: 
Drug users had been accessing treatment and stabilising their drug use through 
substitute prescribing… but not necessarily exiting treatment successfully, fully 
overcoming their addiction and reintegrating into the community (Duke 2013:47; 
see also e.g. Easton 2006; Ashton 2008). 
This call was most vigorously taken up by right-wing think tanks and politicians, and in 
the run-up to the 2010 general election the Conservative manifesto ‘promised to deliver 
an abstinence-based drug strategy’ (Duke 2013:44) with ‘benefit cuts for problem drug 
users and compulsory residential rehabilitation’ (ibid.) intended to encourage OST clients 
into total abstinence. Similar principles began to guide drug services’ commissioning and 
delivery, with UK’s National Treatment Agency calling for an end to people being 
‘parked indefinitely on methadone’ (NTA 2010). 
More broadly, the reconceptualisation of OST as a problematic ‘addiction’ was part of a 
move away from a specific focus on heroin as the dominant concern of drug services. 
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Dedicated funding streams for heroin users’ treatment were removed, as a renewed call 
arose for services to focus on ‘the person not the substance’ (Centre for Social Justice 
2007:19) and to expand treatment for cannabis, alcohol and other drug users. 
Nonetheless, heroin use continues to act as a specific marker for social disadvantage and 
particular difficulties in achieving recovery outcomes (e.g. Advisory Council on the 
Misuse of Drugs (ACMD) 2013; ACMD 2015). The rise of recovery services and the 
removal of protected funding arrangements for heroin users thus raises particular 
questions about the position of heroin users within new service models (ACMD 
2013:17). The ACMD’s Recovery Committee cites US population studies indicating ‘that 
most people who experience a period of dependence on alcohol, cocaine, or cannabis, 
overcome that dependence and remission is the ‘norm’’ (ACMD 2013:10), making such 
individuals appealing targets for recovery services in an era of performance monitoring, 
regular recommisioning, and the prospect of Payment by Results (HM Govt 2010:20). 
Simultaneously, the ACMD advises tempered expectations of recovery outcomes for 
heroin users, contending that the most straightforward routes to abstinence, ‘forced 
detoxification and time-limited opioid prescribing’ (2013:17), lack an evidence base and 
may cause harm. Instead, the report calls for ‘an extensive approach… for a number of 
years, especially for the UK population of ageing heroin users’ (2013:54). Changes to 
service structures consequently have the potential to place unrealistic expectations on 
heroin users, whilst withdrawing any protection for their levels of funding.  
One of the core factors hindering heroin users’ progress towards abstinence is their lack 
of ‘recovery capital,’ defined by White and Cloud as… 
…the quantity and quality of internal and external resources that one can bring to 
bear to initiate and sustain recovery from addiction (2008:29). 
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As Cloud and Granfield surmise, a priori this has weighty implications for an 
individual’s prospects of achieving recovery outcomes: 
An individual’s capacity to terminate chronic substance misuse is very much a 
function of the resources that s/he has developed and maintained over the course of 
his / her life (Cloud and Granfield 2008:1981). 
Indeed, the 2010 Drug Strategy acknowledges this, and clearly identifies that recovery 
services should build ‘on the recovery capital available to [service users]’ (HM Govt  
2010:18).  
Studies have found that heroin users have fewer recovery resources than people 
dependent on other drugs (Jones et al 2007; Social Exclusion Unit 2002), whilst heroin 
dependent offenders are more disadvantaged still. When compared with other arrestees, 
Boreham et al identified that heroin users had one-fifth the levels of employment, and 
were three times as likely to be sleeping rough (2007:24-25). Half had left school before 
the age of 16, and a similar proportion grew up in care (Boreham et al 2007:25-26). 
Heroin dependence is also strongly associated with prolific, acquisitive offending, with 
criminal records further limiting people’s access to social integration (Godfrey et al 2003; 
Holloway and Bennett 2004). In this context, heroin users’ journeys towards abstinence 
are likely to be prolonged, comprising a series of incremental steps. As Duke (2013) 
notes, this potentially creates tension between recovery services and the heroin users they 
engage. Whilst approaching recovery as a person-centred ideal might support clients in 
choosing long-term or indefinite ‘medication assisted recovery’ (Strang 2012:5; ACMD 
2015), abstinence may be heavily promoted as a service- or population- level goal (Duke 
2013:45). 
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The relationship between recovery, heroin use and abstinence is still more problematic in 
a prison setting. Reviewing data from 48,771 prison releases in 1998-2000, Farrell and 
Marsden found that ‘relative to the general population, male prisoners were 29 times 
more likely to die in the week following release, while female prisoners were 69 times 
more likely to die during this period’ (2008:254). Overwhelmingly, excess deaths were 
attributable to opioid toxicity (Farrell and Marsden 2005:41). Averting this elevated risk 
of death continues to be cited as a robust, prima facie rationale for prison-based 
maintenance OST (e.g. Patel 2010:21; WHO 2010:8; DoH and Addaction 2004:11). 
Practical concerns also constrain the delivery of ambitious programmes. Prisons have 
absorbed a 41 per cent reduction in officer numbers between 2010-14, accompanied by a 
rise in assaults, self-harm, deaths in custody, concerted indiscipline, and prisoner 
complaints (House of Commons Justice Committee 2014:28-32). This difficult context 
may obstruct the creation of a therapeutic environment.  
Indeed, prison prescribing continues to prioritise harm reduction. The UK Department of 
Health’s Updated Guidance for Prison-Based Opioid Maintenance Prescribing (2006) 
presents maintenance regimes as the default response to heroin-dependent people 
detained on remand (pre-trial detention), or serving short-term sentences. Only prisoners 
serving longer than six months in prison are expected to engage with a reduction regime. 
In the five years after these guidelines were introduced, maintenance prescribing nearly 
tripled (from 12,158 to 33,198 treatment episodes), whilst detoxification dropped by one 
third (from 46,291 to 31,178 treatment episodes) (Hansard 3
rd
 December 2012: column 
667W). In 2013, the NOMS Director of Health directly identified DoH guidance as the 
main reason that prisons had not ‘adjusted drugs treatment strategies… away from 
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maintenance towards abstinence-based programmes’ (Home Affairs Committee 
2012:202). 
Thus, while the ‘recovery revolution’ (White 2007) may have established firm roots in 
community services, prisons’ OST provision appears to have moved in the opposite 
direction. As DRWs represent an attempt to extend the recovery agenda to prisons, and 
the recovery agenda has clear implications for heroin users and OST prescribing 
practices, this paper explores how this shaped work with opiate dependent prisoners in 
the nine adult pilot DRW prisons. 
Methodology 
In 2012 the Department of Health commissioned the University of York to lead a team of 
researchers from York, Glasgow and Cambridge to undertake a process and impact 
evaluation of pilot Drug Recovery Wings. The evaluation aims to provide a detailed 
description of the operation of individual DRWs and to assess the degree to which 
participation within a DRW facilitates individual prisoners’ recovery and rehabilitation.  
To inform site selection for the full process and impact studies, in early 2013 five 
researchers undertook rapid assessments of the one Welsh and nine English NOMS pilot 
DRWs. Rapid assessment methodologies are common in the development of health-
focused interventions, with Stimson et al identifying ‘83 rapid assessment studies on 
substance misuse, involving 322 different sites in 70 countries’ between 1993 and 2001 
(2006:288). Rapid assessments are not standalone projects, but are likely to be positioned 
at the beginning of larger practice-focused or pure research projects (Stimson et al 
1998:22). They can be broadly understood as scoping exercises, intended to develop a 
rich understanding of local contexts before full interventions or large-scale research 
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projects commence. Rapid assessments offer a highly effective means of carrying out 
such a scoping exercise, and are defined by several features (Stimson et al 1998:26). Key 
amongst these are swiftness, the use of multiple data sources, securing respondents in 
multiple roles, and the use of extant data, all situated within an inductive research 
framework (Stimson et al 1998:22-3). These principles structured the fieldwork, data and 
analyses presented in this paper. 
Researchers aimed to conduct semi-structured interviews with ten DRW staff and ten 
DRW prisoners in each institution, securing a total of 94 staff and 102 prisoner 
interviews. As is often necessitated by prison research (e.g. Heidari et al., 2007; Green et 
al., 2005; Loeb and Steffensmeier 2006), this latter represented a convenience sample. 
Fieldwork was conducted at short notice, during prisoners’ working days, and in wings 
managing turnovers of up to ten new arrivals each day. In this context, full lists of wing 
residents were unavailable, and the availability of given prisoners could not be 
guaranteed. Researchers thus relied on staff to identify and unlock prisoner interviewees, 
though when specific interviewees were requested (following encounters on prison 
landings, for example) they were invariably secured. As this paper focuses on heroin 
dependence – which is very rare in young offender populations – only data from adult 
prisons are reported here. 
All interviews were fully transcribed. NVivo 9 was used to code and analyse all 
transcripts, using an emergent and grounded coding system (Seale 2004:243-4). This 
progressed through an axial coding stage to a fully selective coding system (Seale 
2004:244). Researchers also had access to National Drug Treatment Monitoring System 
(NDTMS) data for prisons in 2012-13. NDTMS is a Public Health England recording 
system, which collates data for all people accessing drug treatment in England. NDTMS 
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data was used to identify the proportion of self-identified heroin users accessing two 
prisons’ treatment services. 
Findings 
Overview 
The DRW pilots adopted contrasting approaches to nearly every aspect of recovery, 
making generalisation difficult. Levels of psychosocial treatment varied between twenty 
minutes per month and twenty-nine hours per week, with the most intensive schedules 
akin to community-based residential rehabilitation. The formal role and qualifications of 
therapeutic staff varied too. Prison officers, registered nurses, and staff employed by 
private contractors were responsible for delivering treatment on various DRWs. Some 
private contractors recruited inexperienced practitioners with few formal qualifications, 
whilst others sought experienced staff with postgraduate counselling qualifications. 
SMART recovery (a structured programme of motivational enhancement and cognitive 
behavioural therapy) and twelve-step fellowship meetings constituted the most 
widespread form of support, available in four prisons apiece. Beyond this, two DRWs 
offered manualised (and nationally accredited) structured group programmes, and two 
facilitated intensive twelve-step courses. Staff elsewhere developed local recovery 
programmes. 
Pilot DRWs also adopted differing recruitment strategies, which shaped the four ‘types’ 
of DRW presented in this paper. Type A DRWs (hereafter referred to as ‘Comprehensive 
Clinical Services’) were large, clinical units. All prisoners receiving OST were housed in 
these units, alongside anyone undergoing clinical detoxification for non-opiate drug or 
alcohol dependence. Only one prison had a Type B (‘Selective Clinical’) DRW. Here, 
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staff sought to build a recovery-focused community of fifty motivated OST recipients, 
recruited from a prison-wide caseload of 270. Type C (‘The Person, Not the Substance’) 
DRWs were mid-sized, and recruited anyone who aspired towards long-term abstinence. 
OST was not a recruitment priority (though those on high doses had to reduce before 
entering the wing), and prisoners with any historic drug or alcohol dependence could 
apply. Finally, Type D (‘The Power of Few’) DRWs were very small. Staff purposively 
recruited ‘mixed cohorts’ of abstinent and medicated prisoners, but anyone receiving 
OST was expected to detoxify before graduation and release.  
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Table 1. Drug Recovery Wings: basic characteristics, and DRW ‘types’. 
 
 
DRW 
Kind of 
Prison 
Beds 
(DRW clients) 
% of prison 
population DRW ‘type’ 
DRW 1 
Category B 
men’s 
132 (88) 23% Type A 
(‘Comprehensive 
clinical’) DRW 2 
Category B 
men’s 
140 (92) 23% 
DRW 3 
Category B 
men’s 
60 (50) 5% 
Type B 
(‘Selective 
clinical’) 
DRW 4 
Category C 
men’s 
60 (40) 5% 
Type C 
(‘The user, not 
the drug’) 
DRW 5 
Category B 
men’s 
49 (49) 11% 
DRW 6 
Category B 
men’s 
90 (60) 6% 
DRW 7 
Category A 
men’s 
22 (18) 1% Type D 
(‘The power of 
few’) 
DRW 8 Women's 20 (7) 2% 
DRW 9 Women's 22 (11) 2% 
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Type A: Comprehensive Clinical Services  
Type A consisted of two large DRWs, which commenced and sustained prescribing for 
all heroin dependent people entering their prisons. Indeed, OST was only available on 
other wings in exceptional circumstances, meaning that prisoners wishing to be housed 
on other locations faced ‘rapid detoxification supported by BritLofex’ (Staff, Prison 1). 
Staff estimated that ‘one to two per cent’ of heroin dependent arrivals chose this option, 
and reported that very few residents attained abstinence from OST. 
Several factors made abstinence an ambitious goal for Type A DRWs. Firstly, treatment 
was sparse. Residents could access one psychosocial one-to-one each month. Neither 
DRW delivered any group programmes (or interventions focused on building recovery 
capital), and several prisoners identified medication as the only meaningful support: 
I: What have the most helpful things been? 
R: The methadone, really. 
I: Anything else… you’ve found helpful? 
R: Not really (Prisoner, Prison 1). 
Indeed, medication was the sole eligibility criterion for Prison 1’s DRW. Those who 
attained abstinence were transferred to other wings, and DRW staff routinely advocated 
for sustained prescribing over detoxification: 
The nurse and I both said it simultaneously, “we don’t think [abstinence] is a good 
idea…” (Staff, Prison 1). 
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Staff estimated that 70% of Type A DRW residents were on pre-trial detention, or serving 
sentences of less than six months. Few such prisoners appeared keen to reduce their OST 
prescriptions: 
People don’t [withdraw] voluntarily. None of these people have been detoxing on 
their own request (Staff, Prison 2). 
Certainly, some prisoners were fraught at the prospect of reduction. One stated 
Without [Subutex] I’d hurt myself and cut my wrists, because I can’t cope without 
it (Prisoner, Prison 2). 
A second asserted his right to indefinite opioid maintenance, on the grounds of being 
‘free from torture and humane, article eight, paragraph eight’. Whilst Article Eight of the 
Human Rights Act has no eighth paragraph and describes the right to a private and family 
life, this prisoner was clearly aware of a legal background to OST prescribing in prisons 
and keen to assert his right to it.  
Whilst staff interviewees described practices that were structured by an awareness of the 
risk of post-release overdose, it seemed striking that none of our prisoner interviewees 
identified a fear of overdose as a reason for delaying medication abstinence. Prisoners’ 
reluctance to detoxify may have consequently been rooted in their strikingly low levels of 
recovery capital. Of nineteen interviewees, just one was serving his first sentence. Nearly 
all had experienced extensive homelessness, and most entered Type A DRWs whilst 
vulnerable and withdrawing. Within an OST-based wing, the black market for diverted 
medication then offered this cohort both opportunities and risks. Some might become 
customers, getting into unmanageable debt; whilst others approached medication and 
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drug dealing as a valuable resource. Staff certainly believed many DRW residents 
actively sought imprisonment whilst ‘packed up [with drugs] to sell’ (Staff, Prison 1), 
and one prisoner reflected:  
They’re running around, swapping their scripts. The majority of them, all they’re 
interested in is getting out of their nut (Prison 1). 
The increased availability of drugs thus made abstinence more challenging for vulnerable 
residents, whilst the black market value of medication may have discouraged some others 
from detoxification. Succinctly, bigger prescriptions offered more illicit opportunities. 
Type B: Selective Clinical 
Prison 3 situated its fifty-bed, Type B DRW in a seventy-bed wing, with the remaining 
beds occupied by non-programme prisoners. The DRW was devised as a psychosocial 
service for only highly motivated OST recipients, and housed less than one-fifth of the 
prison’s full OST caseload. It was originally hoped that ‘creaming off’ (Lipsky 2010:107) 
highly motivated medicated prisoners would foster an abstinence-minded community in 
which prisoners regularly detoxified before transferring to the prison’s abstinence-
focused therapeutic community. In practice, this had not happened. 
Abstinence had proven elusive for several reasons. Firstly, structured intervention was 
limited. Standard treatment consisted of five ‘induction’ groups covering basic harm 
reduction advice, followed by one psychosocial appointment per month. Secondly, the 
separation of psychosocial, clinical and prison officers complicated abstinence. 
Recruitment was carried out by psychosocial workers, who struggled to find abstinence-
minded OST recipients: 
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We can’t get prisoners on [the DRW]… “Oh, you’re going to get us on there and 
you’re going to forcibly detox us” (Staff, Prison 3). 
They consequently stopped advertising any association between the DRW and OST 
reduction: 
We don’t want to… tell people that by coming on here you’re being forced to 
reduce (Staff, Prison 3). 
Psychosocial support on the wing was then delivered by prison officers, who felt 
unqualified to participate in clinical discussions: 
I can’t [say to] one of my lads “listen, you’re on 20mls you’ve got to come down to 
17, 18”… We can’t get involved because it’s the nurse, the healthcare team and him 
(Staff, Prison 3). 
With neither prescribers nor prisoners pushing for abstinence, officers described several 
wing residents staying on stable prescriptions for over a year. 
Finally, it seemed likely that the scarcity of abstinence was related to prisoners’ lack of 
recovery capital. Interviewees had served a mean of ten previous prison sentences, and 
only one had a history of employment. Clinical staff described prisoners arriving 
malnourished, with dire mental health, dental problems, and ‘a lot of wounds that have 
just been left’ (Staff, Prison 3). Opportunities to build recovery capital were also sparse, 
consisting of access to the gym and occasional cookery classes. In this context, senior 
staff had come to see abstinence as highly ambitious: 
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I don't think [recovery] means abstinence because I’m not sure how realistic [that 
is] (Staff, Prison 3). 
Prisoners concurred. Only one interviewee aspired towards abstinence before release, 
with others preferring stability and a transfer to community services: 
Lately I’ve been dropping two mil [of methadone per month]. Now I think I’m 
gonna chill [and] go onto Subutex when I’m out (Prisoner, Prison 3). 
Prison data on 112 DRW completions in 2012-13 identified only three transfers to Prison 
3’s abstinence-based treatment unit.  
Type C: ‘The Person, Not the Substance’  
Type C DRWs operated in three prisons, and were distinguished by their primary focus 
on abstinence. Each housed between 40 and 60 prisoners and, though none intentionally 
excluded former heroin users, they proved scarce: 
We’ve got cannabis, alcohol, crack cocaine. We’ve got ecstasy users. And 
interestingly, this morning we only had one heroin user (Staff, Prison 6). 
Staff in Prisons 4 and 6 confirmed that, respectively, 11% and 2% of DRW residents had 
histories of opiate dependence. Contrastingly, NDTMS data for 2012-13 shows that 35% 
of all prisoners accessing treatment in Prison 4, and 55% of those in Prison 6 named 
heroin as their drug of choice. Prison 5 was in Wales, meaning that NDTMS data were 
unavailable. Lead staff also felt unable to ask for information on opioid prescribing from 
clinical colleagues. The only officer who estimated the proportion of prisoners on the 
DRW who were prescribed methadone put the proportion at 5-10%, based on the number 
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of prisoners queuing up for methadone in the DRW’s daily, dedicated methadone round. 
This suggested that opiate users were likely to be less prevalent in the DRW than in 
prison-wide treatment services. 
Type C DRWs formally disavowed themselves of any interest in drug of choice, seeing 
‘addiction’ as a generic construct and abstinence as the most meaningful response. Within 
this framework, generic motivation towards change became the main selection criterion:  
It’s irrelevant, their drug of choice. It could just be cannabis. It could just be 
alcohol. It could be crack-cocaine-heroin-everything… Do they want to change? 
(Staff, Prison 6). 
A second criterion imposed a cap on applicants’ levels of medication. No Type C DRW 
accepted anyone who was prescribed more than 40 millilitres of methadone, or two 
milligrams of Subutex. This excluded some OST recipients from the DRW, though not 
enough to fully explain the scarcity of former heroin users. A governor in Prison 6 stated 
that ‘we’ve got circa 120 men that are taking 2 mils or less of methadone’ prison-wide. 
Just one was in the DRW.  
A distinctive Type C DRW cohort emerged, defined by cannabis, cocaine and alcohol 
dependency, and high levels of recovery capital. Very few had served more than two 
prison sentences, with thirteen (of twenty-five, for whom data was secured) imprisoned 
for the first time. In DRW 5 and 6, nearly all interviewees had robust employment 
histories and secure future housing – often with partners and children awaiting their 
release. Even DRW 6’s sole opiate dependent resident was notable for his social 
conformity: 
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I did depend on codeine a little bit when alcohol was taken away from me. But as a 
habit… it probably only ever really appealed to me because you could buy it over 
the counter. It wasn’t exactly illegal so I didn’t see them as being as despicable as 
the rest of them to be addicted (Prisoner, Prison 6). 
As he reflected, his access to recovery capital was longstanding: ‘I grew up in [a] middle 
and higher class background.’ 
Staff attributed the scarcity of OST recipients on DRWs to their particular lack of 
motivation: 
Clients on methadone and Subutex aren’t… motivated. [They] just want to come in, 
get their two mils a day, sit in their cells, not go to work, not get in employment, 
nothing (Staff, Prison 6). 
However, it also seemed likely that social factors shaped the constitution of these wings. 
Long-term medication unites opiate users, distinguishing them from all other prisoners: 
those with any other drug of dependence are fully detoxified within two weeks of 
entering prison. This supports two forms of exclusion. Firstly, for so long as OST 
recipients are defined by their access to medication, abstinence-focused wings risk 
sending an implicit message that they are for everyone except heroin users. This message 
could be strengthened by housing all heroin users on dedicated ‘stabilisation wings.’ 
(This was the case in Prison 6, whose DRW housed the lowest proportion of heroin users 
across sites.) Secondly, heroin users lie towards the bottom of any hierarchy of drug users 
(e.g. Lloyd 2013). This was certainly the case in many rapid assessment DRWs: 
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“Ah you’re a smackhead a dirty scumbag. Fucking rob your nan” and all that. You 
do get that [from other prisoners] (Prisoner, Prison 1). 
For OST recipients, DRWs that were dominated by alcohol, cannabis and cocaine users 
could consequently be intimidating environments. This may have further deterred 
applications.  
Type D: ‘the Power of Few’  
Type D DRWs consisted of three very small units (including both of those in women’s 
prisons), each housing between eight and twenty prisoners. None held more than 2.4 per 
cent of their parent prison’s population.  
Working with very small cohorts, staff in Type D DRWs felt that they were particularly 
successful at supporting former heroin users through OST detoxification. At least half of 
each site’s residents had histories of heroin use, and were recruited whilst still prescribed 
OST. However, very rapid reduction regimes and complete detoxification were the norm. 
Full detoxification was expected of all residents in Prisons 7 and 8, with suggested 
completion rates as high as ‘ninety per cent’ (Staff, Prison 7). No such formal 
requirement existed in Prison 9, but its DRW residents still described some of the fastest 
reductions from the highest doses encountered across sites.  
OST recipients’ willingness to detoxify appeared to be supported by several factors. From 
the outset, staff recognised the scale of the challenge presented by detoxification, and 
purposefully housed ‘stabilising populations’ of fully abstinent prisoners (many of whom 
had histories of alcohol dependence) alongside those with OST prescriptions. 
Professional support was both intensive (a minimum of nineteen hours per week, mostly 
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comprising group treatment), and geared towards the development of strong peer groups: 
all Type D DRW prisoners undertook treatment together. 
Sharing both group therapy and accommodation seemed to support the emergence of safe 
therapeutic spaces. Emotional vulnerability, a sign of weakness on other wings, became a 
source of shared strength and personal development: 
[Victim awareness] was stressful, it was upsetting, I did cry. [But] we've got nine 
other guys who… were looking at it cold stone sober. We were there to support 
each other, If it was just one on one, I think I would have gone away and got really 
depressed… but doing it within the group… really helped (Prisoner, Prison 8). 
Within these environs, OST recipients detoxified apace. Staff in Prison 7 described 
several going ‘cold turkey’ from 20 millilitres of methadone, willingly committing to a 
level of physical and emotional hardship that was unheard of in some other DRWs. In 
Prison 9, medicated interviewees described sustained reduction regimes of ten millilitres 
of methadone per week from initial doses as high as 180mls. Nearly all interviewees who 
were medicated on arrival had either achieved abstinence, or were well on the way to 
attaining it.  
Prisoners presented their peers as the most essential element of their recovery 
communities. Detoxification was supported in ways that seemed unimaginable on other 
wings: 
Upstairs… people come in, “oh, why don’t you go and get this… they’ll sort you 
out [with drugs].” Down here, they were coming in and talking to me [when] I was 
lying on the bed. “You know, you’ll be alright” (Prisoner, Prison 7). 
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Contrary to the ‘no grassing’ ethos that dominates many prisoners’ lives (see, for 
example, Crewe 2009:241-253; Sykes and Messinger 1960:6), when a dealer was 
‘lodged’ in one DRW the residents took swift action: 
We all went [to the staff] and said, “look, we’re not having it” (Prisoner, Prison 9). 
Residents in Type D units thus took responsibility for promoting pro-recovery behaviours 
within their peer group, whilst ‘policing out’ negative influences. 
Discussion 
Pilot DRWs were established with the intention of bringing recovery into prisons, by 
establishing ‘wing-based, abstinence-focused recovery services’ (HM Govt 2010:12) to 
recruit ‘offenders who have the goal to be drug free’ (PIRU 2012:2). In this rapid 
assessment, it seemed striking that only staff in very small, hyper-selective, Type D 
DRWs claimed to routinely support former heroin users through a full detoxification 
process. This resonates with the findings of the ACMD (2013), and raises several queries 
about the place of imprisoned heroin users within recovery services. 
Firstly, do imprisoned heroin users want abstinence? In the much-referenced Drug 
Outcomes Research in Scotland (DORIS) study, McKeganey et al identified that across 
prison and community samples, ‘56% of drug users cited that becoming drug free was 
their sole goal from treatment’ (2008:16). Whilst this may be the long-term goal of many 
heroin users it is notable that the question does not unpick what respondents understood 
by ‘becoming drug free’, or if this included detoxification from OST (Neale, Nettleton 
and Pickering 2011): the aspect of treatment that spurred the emergence of a recovery 
movement, and that proved most elusive for former heroin users in pilot DRWs. Indeed, 
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prioritising motivation towards abstinence and requiring sustained progress towards that 
goal appeared to filter out former heroin users from DRW treatment populations. This 
was most starkly highlighted in Prisons 3 and 6, which each had both abstinence-focused 
and OST treatment wings (though they differed in which of these was called a ‘DRW’). 
The abstinence-focused wings overwhelmingly housed formerly cocaine, alcohol and 
cannabis dependent prisoners (and one former codeine user); the OST wings exclusively 
housed former heroin users. To the frustration of staff, the two populations did not seem 
to mix.  
This may reflect a divide between person-centred and service-level recovery goals in 
particular service user groups (Duke 2013:45). When creating services that explicitly 
pushed for medication abstinence, DRWs only attracted those who found these goals 
personally appealing. Building on the ACMD’s (2013) expectation that former heroin 
users will benefit from long-term extensive treatment journeys, units wishing to support 
OST recipients in making greater progress towards abstinence may benefit from 
developing stepped treatment journeys premised on considerably more preparatory 
motivational work (e.g. Prochaska, Norcross and DiClemente 1997), and extensive 
preparation for release.  
Secondly, why might imprisoned heroin users be particularly reluctant to detoxify? 
Systemic, structural and social factors all seem relevant here. Systemically, only OST 
recipients have to ‘choose’ abstinence in prison. Heroin users held on remand or serving 
short-term sentences can expect maintenance prescribing (DoH 2006), and are the only 
group whose dependence and tolerance is actively sustained in order to avert a risk of 
post-release overdose (Farrell and Marsden 2005; Farrell and Marsden 2008; DH 2006). 
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All other prisoners are fully detoxified within two weeks of entering prison, and are 
consequently eligible for abstinence-focused DRWs by default.  
Structurally, heroin users are disadvantaged by their lower levels of recovery capital 
(ACMD 2013; Cloud and Granfield 2008; Laudet and White 2008). This was reflected 
within this study; when compared with Type C DRW cohorts, interviewees in Type A 
and B units had few resources with which to attain abstinence and few reasons for 
desiring it. After interviewing middle-class former drug users, Cloud and Granfield were 
surprised when a poor, unwell, inner-city interviewee asked:  
“Get clean for what – to feel miserable all the time?” (2008:1979). 
This bleak statement adequately reflects the challenge sobriety presented for many more 
marginalised interviewees, who realistically expected to face poverty, broken families, 
homelessness or dire housing, skills shortages, unemployability, and poor mental health 
following their release. This resonates with Cloud and Granfield’s conclusion: 
Whilst persons from various backgrounds can be “susceptible” to chronic substance 
misuse, the capacity for successfully terminating these problems after they occur is 
not equally distributed across all sections of society (2008:1981). 
From a staff perspective, encouraging heroin dependent prisoners to make headway 
against such disadvantage may appear questionable due to the greatly elevated risk of 
death abstinence presents (Farrell and Marsden 2005; Farrell and Marsden 2008).  
Finally, in social terms, heroin users are at the bottom of drug users’ and prisoners’ 
hierarchies (Crewe 2009; Lloyd 2013). OST groups former heroin users together, 
sometimes segregated from other prisoners in dedicated, medicated wings. Applying to 
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an abstinence-focused treatment unit may be a bold step for this group, requiring a move 
to a wing where they do not ‘belong’. This may go some way towards explaining the 
situation in Prison 6, wherein staff believed ‘over 120 men’ were staying on low-dose 
OST to avoid being transferred to other wings. 
This systemic, structural and social context seems highly significant in understanding the 
lived meaning of motivation towards abstinence. In regarding drug of choice as 
‘irrelevant’ to recruitment and selection, Type C DRWs ignored the fundamental 
inequalities that undergird motivation towards abstinence – and that, by proxy, define 
heroin users and their ‘place’ within prisons (Hannah-Moffat 2001; ACMD 2013). 
Formal equality of opportunity consequently led to real-world inequality of access. 
This leads to a final question: what kind of services might safely support imprisoned 
heroin users into abstinence? This is a challenging question to answer, and it is not 
without reason that the 2010 Drug Strategy (HM Govt) emphasised a need for services to 
work with clients’ existing recovery capital. As Best and Laudet reflect, recovery capital 
is very hard for services to develop / enhance: 
It is not direct treatment effects that will trigger the growth of recovery capital; 
rather, it is likely to be a range of life events and personal and interpersonal 
transitions: attachment to a conventional person (spouse); stable employment; 
transformation of personal identity; ageing; inter-personal skills; and life and 
coping skills. However, this does not mean that treatment providers or 
commissioners have nothing to offer – they are often best placed to act as guides to 
recovery communities, and they are essential in activating the basic health supports 
that are needed (2010:5-6). 
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Strikingly, services focused on building recovery capital were generally absent from 
DRWs. Indeed, in many ways prison militates directly against the nurturing and 
development of recovery capital (Cloud and Granfield 2008). With jobs that pay top-end 
wages of less than £15 per week, short-term prisoners can hardly hope to develop the 
‘economic or financial capital’ that comprises physical capital, or social capital in the 
guise of ‘membership in a social group [that] confers resources, reciprocal obligations, 
and benefits on individuals who may use this ”stock” to improve their lives’ (Cloud and 
Granfield 2008:1973). Indeed, the most prison-based services might realistically hope to 
achieve with multiply marginalised short-term prisoners is basic restitution of their 
capacity to negotiate daily life through knowledge, skills and education (human capital), 
and a realigning of DRW residents’ worldview to accord with conventional pro-social 
norms (cultural capital) (Cloud and Granfield 2008:1974). 
To achieve this, meaningful interventions must be able to make headway against decades 
of structural disadvantage and systemic marginalisation. Type D DRWs appeared to 
thrive, increasing the impact of limited resources by engaging very small numbers of 
prisoners. Small wings may also offer advantages that cannot be upscaled, and that make 
them particularly well suited to supporting populations with high levels of complex need. 
Large wings present significant security problems (Woolf 1991). They also offer 
residents less secure and stable prisoner communities, and foster poorer interactions with 
staff (Johnsen and Granheim 2011; James 2003; Henley 2003). Contrastingly, small 
wings have a robust history of supporting cohesive, accountable and therapeutic 
communities, even in highly challenging populations (Johnsen 2011; Henley 2003; James 
2003:97; Stevens 2013:172; Cooke 1989). Having the capacity to be highly selective, and 
to house ‘role model’ abstinent prisoners alongside those who are receiving OST, 
29 
 
supports small wings in creating a sense of shared ‘recovery purpose’ (Pawson 
2006:146). As Deegan reflects, this is important because… 
…it becomes very difficult to continue to convince oneself that there is no hope 
when one is surrounded by people who are making strides in their recovery! 
(1988:58). 
Insofar as the scale of large, unselective wings made it hard to build momentum for 
change, Type D DRWs consequently seem well-designed for supporting marginalised, 
recovery-curious imprisoned heroin users (ACMD 2013). 
Framed by this context, McKeganey et al reflect that larger prison-based interventions 
will require substantial resourcing if they are to effectively support highly marginalised 
groups: 
This must mean expanding the availability of treatments which contain the 
flexibility and range of skills required to address the diversity and complexity of 
prisoners’ needs… However, all of these have very significant resource 
implications. All… perform best the more that is invested in them (2008:2). 
In the case of pilot DRWs, it seems likely that limited ongoing funding determined their 
capacity to deliver highly ambitious outcomes in an inordinately challenging group: no 
pilot DRW offered intensive treatment to large groups of heroin users, and large wings 
turned OST and abstinence into very uneasy bedfellows. To a considerable extent, this 
unintentional divide mitigated any potential concerns about the greatly elevated risk of 
overdose imprisoned heroin users might face should they attain medication abstinence 
(Farrell and Marsden 2005; Farrell and Marsden 2008). Nonetheless, it raises questions 
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for prison-based recovery services who, in the likely absence of additional resourcing, 
may benefit from explicitly choosing which to prioritise: unit size; ambitious recovery 
goals; or small gains within the most disadvantaged and socially costly of client groups.  
 
Declaration of interest 
This is an independent report commissioned and funded by the Policy Research 
Programme in the Department of Health. The views expressed are not necessarily those 
of the Department. 
 
  
31 
 
References 
Advisory Council on the Misuse of Drugs (2013). What Recovery Outcomes does the 
Evidence Tell Us We Can Expect? Second Report of the Recovery Committee. London: 
ACMD  
Advisory Council on the Misuse of Drugs (2015). How can Opioid Substitute Therapy 
(and Drug Treatment Recovery Systems) be Optimised to Maximise Recovery Outcomes 
for Service Users. London: ACMD 
Ashton, M. (2008). The new abstentionists. Druglink Special Insert, Dec / Jan 2008, 1-16 
Best, D., and Laudet, A.B. (2010). The Potential of Recovery Capital. London: RSA 
Boreham, R., Cronberg, A., Dollin, L., & Pudney, S. (2007). The Arrestee Survey 2003-
2006. Home Office Statistical Bulletin. London: Home Office RDS Directorate 
Centre for Social Justice (2007). Breakthrough Britain: Addictions. London: Centre for 
Social Justice 
Cloud, W., and Granfield, R. (2008). Conceptualising recovery capital: expansion of a 
theoretical construct. Substance Use and Misuse, 43, 1971-1986 
Cooke, D.J. (1989). Containing violent prisoners. An analysis of the Barlinnie Special 
Unit. British Journal of Criminology, 29(2), 129-143 
Crewe, B. (2009). The Prisoner Society. Power, Adaptation and Social Life in an English 
Prison. Oxford: OUP 
32 
 
Deegan, P.E. (1988). Recovery: the lived experience of rehabilitation. Psychosocial 
Rehabilitation Journal, 11, 11-19 
Department of Health (2006). Updated guidance for prison based opioid maintenance 
prescribing. London: Department of Health 
Department of Health & Addaction (2004). National Aftercare Research Project Report. 
Year 1. London: Addaction  
Duke, K. (2013). From Crime to Recovery: The Reframing of British Drugs Policy?, 
Journal of Drug Issues, 43, 39-55  
Easton, M. (2006). Drug Services Make Slow Progress. Retrieved 10
th
 June 2014 from 
http://news.bbc.co.uk/1/hi/uk/7068572.stm  
Farrell, M., and Marsden, J. (2005). Drug-Related Mortality Among Newly-Released 
Offenders 1998 to 2000. Home Office Online Report 40/05. London: Home Office. 
Farrell, M., and Marsden, J. (2008). Acute risk of drug-related death among newly 
released prisoners in England and Wales. Addiction, 103, 251-255 
Godfrey, C., Stewart, D., & Gossop, M. (2003). Economic analysis of costs and 
consequences of the treatment of drug misuse: 2-year outcome data from the National 
Treatment Outcome Research Study (NTORS). Addiction, 99, 697-707 
Green, B.L., Miranda, J., Daroowalla, A. and Siddique, J. (2005). Trauma exposure, 
mental health functioning, and program needs of women in jail. Crime and Delinquency, 
51, 133-151  
33 
 
Hannah-Moffat, K. (2001). Punishment in Disguise: Penal Governance and Canadian 
Women’s Imprisonment. Toronto: University of Toronto Press 
Heidari, E., Dickinson, C., Wilson, R., and Fiske, J. (2007). Oral health of remand 
prisoners in HMP Brixton, London. British Dental Journal, 202, online article number E5 
Henley, S. (2003). The 21
st
 Century Model Prison. Proceedings of the 4th International 
Space Syntax Symposium London 2003 
HM Government (2002). Updated Drug Strategy 2002. London: HMSO 
HM Government (2008). Drugs. Protecting Families and Communities. The 2008 Drug 
Strategy. London: HMSO 
HM Government (2010). Drug Strategy 2010: Reducing Demand, Restricting Supply, 
Building Recovery: Supporting People to Live a Drug Free Life. London: HM Govt 
Holloway, K. & Bennett, T. (2004). The Results of the First Two Years of the 
NEWADAM Programme. Home Office Online Report 19/04. London: Home Office 
Home Affairs Committee (2012). Ninth Report of Session 2012-13. Drugs: Breaking the 
Cycle. London: The Stationery Office Ltd.  
House of Commons Justice Committee (2014) Prisons: Planning and Policies. Ninth 
Report of Session 2014-15. London: HMSO 
Home Office (2008). The Drug Interventions Programme. Out of Crime, Into Treatment. 
London: Home Office 
34 
 
House of Commons Justice Committee (2014). Prisons: Planning and Policies. Ninth 
Report of Session 2014-15. London: HMSO 
James, E. (2003). A Life Inside. A Prisoner’s Notebook. London: Atlantic Books 
Johnsen, B., and Granheim, P.B. (2011). Prison size and quality of life in Norwegian 
closed prisons in late modernity. In T. Ugelvik and Dullum J. (eds.) Nordic Prison 
Practice and Policy – Exceptional or Not? London: Routledge 
Jones, A., Weston, S., Moody, A., Millar, T., Dollin, L., Anderson, T., and Donmall, M. 
(2007). The Drug Treatment Outcomes Research Study (DTORS): Baseline Report. 
London, Home Office  
Laudet, A.B., and White, W.L. (2008). Recovery capital as prospective predictor of 
sustained recovery, life satisfaction and stress among former poly-substance users. 
Substance Use and Misuse, 43, 27-54  
Lipsky, M. (2010). Street-Level Bureaucracy. Dilemmas of the Individual in Public 
Services. New York: Russell Sage Foundation 
Lloyd, C. (2013). The stigmatisation of problem drug users: a narrative literature review. 
Drugs: Education, Prevention and Policy, 20, 85–95. 
Loeb, S.J., and Steffensmeier, D. (2006). Older male prisoners: health status, self-efficacy 
beliefs, and health-promoting behaviours. Journal of Correctional Healthcare, 12, 269-
278 
35 
 
McKeganey, N., Bloor, M., McIntosh, J., and Neale, J. (2008). Key Findings from the 
Drug Outcome Research in Scotland (DORIS) Study. Glasgow: University of Glasgow 
Centre for Drug Misuse Research  
Ministry of Justice (2010). Breaking the Cycle: Effective Punishment, Rehabilitation and 
Sentencing of Offenders. London: MoJ 
Ministry of Justice (2015). Population bulletin: weekly 20 November 2015. Retrieved 26
th
 
November 2015 from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/478575/pri
son-population-figures-20-nov-2015.xls  
National Treatment Agency (2010). Business plan 2010-11. London: NTA 
Neale, J., Nettleton, S., and Pickering, L. (2011). What is the role of harm reduction when 
drug users say they want abstinence? International Journal of Drug Policy, 22, 189-193 
Patel (2010). The Patel Report. Prison Drug Treatment Strategy Review Group. London: 
HMSO  
Pawson, R. (2006). Evidence Based Policy: A Realist Perspective. London: Sage. 
PIRU (2012). Advisory Note to the Department of Health on the Evaluation of the Drug 
Recovery Wing Pilots Programme. London: London School of Hygiene and Tropical 
Medicine 
Powis, B., Walton, C., & Randhawa, K.(2014). Drug Recovery Wings Set Up, Delivery 
and Lessons Learned: Process Study of First Tranche DRW Pilot Sites. London: Ministry 
of Justice 
36 
 
Prochaska, J.O., DiClemente, C.C., & Norcross, J.C. (1992). In search of how people 
change. Applications to addictive behaviours. American Psychologist, 47(9), 1102–14 
Seale, C. (2004). Validity, reliability, and quality. In C Seale (ed) Researching Society 
and Culture (pp.71-83). SAGE: London  
Seddon, T., Williams, L. and Ralphs, R. (2012). Tough Choices. Risk, Security and the 
Criminalization of Drug Policy. Oxford: OUP 
Skodbo, S., Brown, G., Deacon, S., Cooper, A., Hill, A., Millar, T., Smith, J. and 
Whitham, K. (2007). The Drug Interventions Programme (DIP): Addressing Drug Use 
And Offending Through ‘Tough Choices’. London: Home Office 
Social Exclusion Unit (2002). Reducing Re-Offending by Ex-Prisoners. London: Social 
Exclusion Unit 
Stevens, A. (2013). Offender Rehabilitation and Therapeutic Communities. Enabling 
Change the TC Way. Abingdon: Routledge 
Stimson, G.V., Fitch, C., and Rhodes, T. (1998). The Rapid Assessment and Response 
Guide on Psychoactive Substance Use and Prevention. Geneva: World Health 
Organisation 
Stimson, G.V., Fitch, C., Jarlais, D.D., Poznyak, V., Perlis, T., and Rhodes, T. (2006). 
Rapid assessment and response studies of injection drug use: knowledge gain, capacity 
building and intervention development in a multisite study. American Journal of Public 
Health, 96, 2, 289-295 
37 
 
Strang, J. (2012). Medications in Recovery. Re-Orientating Drug Dependence Treatment. 
NTA: London 
Sykes, G.M. and Messinger, S. (1960) ‘The inmate code and its social functions.’ In R.A. 
Cloward (ed.), Theoretical Studies in the Social Organisation of the Prison. New York: 
Social Science Research Council 
White, W.L. (2007). A recovery revolution in Philadelphia. Counselor, 8, 34-38 
White, W.L. and Cloud, W. (2008). Recovery capital: a primer for professionals. 
Counselor, 9, 22-27 
Woolf (1991) Prison Disturbances, April 1990. Report of an Inquiry. London: HMSO  
World Health Organisation (2010). Prevention of Acute Drug-Related Mortality in Prison 
Populations during the Immediate Post-Release Period. Denmark: WHO Regional Office 
for Europe 
 
 
